Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19
Authors 0
- Author list not loaded yet.
Cited by 1 stored of 3
1 result